Amerise BioScie Board Meeting: Latest Updates and Details

Purpose	Board Meetings Date	Announcement Date
Board Meeting	6 Aug 2024	30 Jul 2024
Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 6th August 2024 inter alia to consider following business. Please take the above intimation in your records. Thanking You. PFA (As per BSE Announcement Dated on 06/08/2024)
Board Meeting	23 May 2024	16 May 2024
Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 23rd May 2024 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financia l Results of the Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. Audited Financial Results of the company for the quarter and year ended on 31st March 2024. Outcome of the Board Meeting held on 23rd May 2024. (As per BSE Announcement Dated on 23/05/2024)
Board Meeting	22 Jan 2024	16 Jan 2024
Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday January 22 2024 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities. Please take the above intimation in your records. Thanking You. PFA (As Per BSE Announcement dated on 13.02.2024)
Board Meeting	7 Nov 2023	26 Oct 2023
Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Tuesday November 7 2023 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2023 and also transact other business activities. Please take the above intimation in your records. Thanking you. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2023 and The meeting commenced at 04.00P.M. and concluded at 04.30 P.M. Kindly take the same on your record and oblige. Thanking You PFA (As Per BSE Announcement Dated on 07/11/2023)

Derivatives

IPO

Mutual Funds

Nifty 50

Loans

Knowledge Center

News

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Disclaimer

Research Disclaimer

Twitter Disclaimer

Advertisement Disclaimer

Terms & Conditions

RBI Policy Update

CSR Policy

Sitemap

ATTENTION INVESTORS

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Amerise Biosciences Ltd Board Meeting

Amerise BioScie CORPORATE ACTIONS

Amerise BioScie: Related News

QUICKLINKS FOR Amerise Biosciences Ltd

Information

Financials

Results

News

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES